- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 01.09. | Picard Medical Aktie bricht ein: Spekulative Gewinne weichen fundamentalen Sorgen | 7 | Investing.com Deutsch | ||
| 24.08. | Why Is Picard Medical Stock Gaining Monday? | 12 | Benzinga.com | ||
| 20.08. | Picard Medical, Inc. - 8-K, Current Report | - | SEC Filings | ||
| PICARD MEDICAL Aktie jetzt für 0€ handeln | |||||
| 19.08. | Picard Medical reports Q2 results | 2 | Seeking Alpha | ||
| 19.08. | Picard Medical, Inc.: Picard Medical Reports Second Quarter 2026 Financial Results | 251 | GlobeNewswire (Europe) | - Revenue Increases 39% and Net Loss Decreases 16%- Year-to-Date Revenue Increases 50%, with ~$0.9 Million in Gross Profit TUCSON, Ariz., Aug. 19, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE... ► Artikel lesen | |
| 19.08. | Picard Medical, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 17.08. | Picard Medical, Inc. - NT 10-Q, Notification of inability to timely file Form 10-Q or 10-QSB | 1 | SEC Filings | ||
| 31.07. | Picard Medical, Inc.: Picard Medical / SynCardia Presents Emperor Total Artificial Heart Architecture for the First Time at IEEE EMBC 2026 | 1 | GlobeNewswire (USA) | ||
| 27.07. | Picard Medical, Inc.: Picard Medical / SynCardia to Present Next-Generation Emperor Total Artificial Heart Technology at IEEE EMBC 2026 | 2 | GlobeNewswire (USA) | ||
| 27.07. | Picard Medical regains NYSE compliance | 2 | Seeking Alpha | ||
| 27.07. | Picard Medical regains compliance with NYSE American listing | 1 | Investing.com | ||
| 27.07. | Picard Medical, Inc.: Picard Medical Receives NYSE American Acceptance of Compliance Plan | 310 | GlobeNewswire (Europe) | TUCSON, Ariz., July 27, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (the "Company" or "Picard Medical"), parent company of SynCardia Systems LLC, maker of the world's first... ► Artikel lesen | |
| 22.07. | Picard Medical announces 1-for-50 reverse stock split to maintain NYSE American listing; stock slips | 3 | Seeking Alpha | ||
| 22.07. | Picard Medical approves 1-for-50 reverse stock split | 4 | Investing.com | ||
| 22.07. | Picard Medical, Inc.: Picard Medical Announces Reverse Stock Split Following Stockholder Approval to Support Continued NYSE American Listing Compliance | 305 | GlobeNewswire (Europe) | -Reverse stock split to support continued compliance with NYSE American continued listing standards- TUCSON, Ariz., July 21, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (the... ► Artikel lesen | |
| 21.07. | Picard Medical, Inc. - 8-K, Current Report | 5 | SEC Filings | ||
| 15.07. | Picard Medical's artificial heart platform reviewed in journal | 2 | Investing.com | ||
| 15.07. | Fachzeitschrift beleuchtet Plattform für künstliches Herz von Picard Medical | 2 | Investing.com Deutsch | ||
| 15.07. | Picard Medical, Inc.: Artificial Organs Publishes Independent Commentary on Picard Medical and SynCardia's Emperor Total Artificial Heart Program | 182 | GlobeNewswire (Europe) | TUCSON, Ariz., July 15, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) ("Picard Medical" or the "Company"), parent company of SynCardia Systems, LLC ("SynCardia"), maker of the... ► Artikel lesen | |
| 13.07. | Picard Medical, Inc.: Picard Medical / SynCardia Releases Annual Stockholder Presentation Ahead of 2026 Annual Meeting | 3 | GlobeNewswire (USA) |
1 2 3 Weiter >>
56 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| HIMS & HERS HEALTH | 26,620 | +0,60 % | Hims & Hers Names Chief Medical Officers in the UK and Australia, Deepening its Investment in Local Clinical Leadership | Kultar Garcha, MD, joins as Chief Medical Officer of the UK and EMEA, and Matt Vickers, FRACGP, MBBS, BMedSci, AICGG, is named Chief Medical Officer of Hims Australia, guiding clinical strategy... ► Artikel lesen | |
| BLUEJAY DIAGNOSTICS | 0,761 | 0,00 % | Bluejay Diagnostics, Inc.: Bluejay Diagnostics Reports Q2 2026 Results; Strengthened Balance Sheet Supports Advancement of Symphony IL-6 Toward Regulatory Submission and Commercialization | SYMON-II pivotal clinical study completes targeted enrollment of 750 patientsCompany advances toward planned 510(k) submission and commercialization with US manufacturing contract signed to mitigate... ► Artikel lesen | |
| TREACE MEDICAL CONCEPTS | 4,480 | 0,00 % | Treace Medical Concepts, Inc.: Treace Announces Results of Three Clinical Studies Including the Milestone 5-Year ALIGN3D Study Demonstrating Sustained, Positive Outcomes of the Lapiplasty Procedure | PONTE VEDRA, Fla., Sept. 17, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. ("Treace" or the "Company") (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical... ► Artikel lesen | |
| FRESENIUS | 43,865 | +0,53 % | Fresenius Kabi erhält Warnung von der US-Gesundheitsbehörde FDA | DJ Fresenius Kabi erhält Warnung von der US-Gesundheitsbehörde FDA
DOW JONES--Die Fresenius-Tochter Kabi hat einen Warnschuss von der US-Gesundheitsbehörde FDA erhalten. In dem am Dienstag veröffentlichten... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 37,450 | -1,08 % | JEFFERIES stuft Siemens Healthineers auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Siemens Healthineers mit einem Kursziel von 50 Euro auf "Buy" belassen. Accela sei ein Quantensprung in der Strahlentherapie... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,250 | +1,77 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 62,03 | +0,05 % | BMO Capital reiterates Outperform on BrightSpring Health stock | ||
| LIFESTANCE HEALTH GROUP | 12,220 | 0,00 % | KeyBanc raises Lifestance Health stock price target on specialty care growth | ||
| HEARTFLOW | 52,24 | +0,06 % | AI Cardiac Diagnostics Pioneer Sets HeartFlow (HTFL) for High-Margin Expansion | ||
| ALIGNMENT HEALTHCARE | 8,500 | 0,00 % | Are Options Traders Betting on a Big Move in Alignment Healthcare Stock? | ||
| CARL ZEISS MEDITEC | 30,440 | -2,75 % | Carl Zeiss Meditec: Das Chartbild sieht spannend aus, aber … | Nachdem Carl Zeiss Meditec im Januar eine Gewinnwarnung veröffentlichte und einbrach, gelang zwar eine Bodenbildung, aber zurück in den Fokus der Käufer gelangte die Aktie nicht mehr. Doch jetzt sieht... ► Artikel lesen | |
| AVEANNA HEALTHCARE | 12,400 | 0,00 % | Aveanna Healthcare Holdings, Inc. - 8-K, Current Report | ||
| HEARTBEAM | 0,667 | +1,96 % | HeartBeam: Aktie schießt nach beschleunigter FDA-Zulassung um 56 % in die Höhe | ||
| QTREX QUANTUM | 1,565 | +1,62 % | Qtrex Quantum jumps 40% | ||
| ANTERIS TECHNOLOGIES GLOBAL | 7,550 | 0,00 % | ANTERIS TECHNOLOGIES GLOBAL CORP.: Notification regarding unquoted securities - AVR |
Das Unternehmen PICARD MEDICAL INC kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell -1,21 % bei einem Aktienkurs von 6,530 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu PICARD MEDICAL INC finden Sie auf Wallstreet Online.